- Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
-
Dutta D, Agarwal A, Maisnam I, Singla R, Khandelwal D, Sharma M
- KMID: 2515464
- Endocrinol Metab.
- 2021 Apr;36(2):374-387.
- doi: 10.3803/EnM.2020.818
Background: No meta-analysis has holistically analysed and summarised the efficacy and safety of gemigliptin in type 2 diabetes. The meta-analysis addresses this knowledge gap. Methods: Electronic databases were searched for randomised... -
- CITED
-
- Close
- SHARE
-
- Close
